Trial site
Wojewódzki Szpital Specjalistyczny w Olsztynie
- 28running trials
- 13closed trials
The trials here
What the 41 trials at this site are about, from their registry records.
- Conditions
- Crohn's disease7 trials
- Chronic kidney disease6 trials
- Multiple sclerosis6 trials
- Ulcerative colitis6 trials
- Coronary artery disease3 trials
- Ovarian cancer3 trials
- Heart failure2 trials
- IgA nephropathy2 trials
- Type 2 diabetes2 trials
- Acute lymphoblastic leukaemia1 trial
- Atrial fibrillation1 trial
- Childhood cancers1 trial
- and 8 more
- Phase
- Phase 332 trials
- Phase 24 trials
- Phase 2/32 trials
- Phase 11 trial
- Phase 41 trial
- Status
- Active, not recruiting16 trials
- Completed13 trials
- Recruiting11 trials
- Not yet recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC6 trials
- AstraZeneca5 trials
- Hoffmann-La Roche4 trials
- TG Therapeutics, Inc.3 trials
- Novo Nordisk A/S2 trials
- and 21 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Cardiovascular Disease in Patients With Chronic Kidney Disease: Polish Kidney- Heart Project
Recruiting
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery Trial (PREVENT-MINS)
Active, not recruiting
Active, not recruiting
Empagliflozin and dapagliflozin for improvement of outcome in patients with acute heart failure
Active, not recruiting
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
Active, not recruiting
Active, not recruiting
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
Active, not recruiting
An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease4 recruiting
- Multiple sclerosis3 recruiting
- Atrial fibrillation1 recruiting
- Coronary artery disease1 recruiting
- Crohn's disease1 recruiting
- Cytomegalovirus infection1 recruiting
- Metastatic breast cancer1 recruiting
- Nephrotic syndrome1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Active, not recruiting
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Active, not recruiting
Completed
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Recruiting
Completed
Completed
A Study of the Effect and Safety of Sparsentan in the Treatment of Patients With IgA Nephropathy
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026